Administration of l-DOPA, dopamine agonists, MAO inhibitors, catechol-O-methyltransferase (COMT) inhibitors and anticholinergics has been shown to temporarily relieve motor and nonmotor PD symptoms but without halting PD progression. Here, COMT is linked to Parkinson disease.